Patient Guides & Clinical Insights
Expert information on medical cannabis prescriptions, conditions, strains and patient experiences in the United Kingdom. Written by clinicians, reviewed for accuracy.
09 May 2026
What Is THCV? THCV (tetrahydrocannabivarin) is a minor phytocannabinoid found primarily in African cannabis cultivars It is structurally similar to THC but…
Read More →
08 May 2026
The Two Principal Cannabinoids: An Introduction THC (tetrahydrocannabinol) is the primary psychoactive compound in cannabis CBD (cannabidiol) is non-psychoactive and the second…
Read More →
08 May 2026
Titration Strategies to Minimise Side Effects Starting at the lowest effective dose and increasing gradually reduces the risk of adverse effects A…
Read More →
08 May 2026
Common Short-Term Side Effects Dry mouth (xerostomia) is one of the most frequently reported side effects of cannabis Dizziness or lightheadedness, particularly…
Read More →
08 May 2026
What Is the Endocannabinoid System? The endocannabinoid system (ECS) is a complex cell-signalling system present in all vertebrates It was discovered in…
Read More →
07 May 2026
What Are Cannabinoid Receptors? Cannabinoid receptors are G-protein coupled receptors that form part of the endocannabinoid system (ECS) Two primary subtypes have…
Read More →
07 May 2026
Common Themes in Patient Feedback Patients consistently report improvements in sleep quality as one of the earliest benefits Pain relief is the…
Read More →
07 May 2026
The Scale of Sleep Disorders in the UK Around one third of UK adults report regular sleep problems Chronic insomnia disorder affects…
Read More →
07 May 2026
Australia’s Therapeutic Goods Administration Framework The TGA regulates medical cannabis in Australia under the Therapeutic Goods Act 1989 Australia uses a Special…
Read More →
07 May 2026
Understanding Diabetic Peripheral Neuropathy Diabetic peripheral neuropathy (DPN) affects up to 50% of people with diabetes over time Around 4.3 million people…
Read More →